ANTI-IL-2 RECEPTOR BT563 VERSUS PLACEBO - A RANDOMIZED TRIAL FOR INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION

Authors
GLANEMANN M LANGREHR JM RAAKOW R GUCKELBERGER O LOHMANN R KLUPP J LOBECK H SCHLAG H KECK H BECHSTEIN WO SETTMACHER U NEUHAUS P
Citation
M. Glanemann et al., ANTI-IL-2 RECEPTOR BT563 VERSUS PLACEBO - A RANDOMIZED TRIAL FOR INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(5), 1998, pp. 2159-2160
Citations number
4
Categorie Soggetti
Transplantation,Surgery,Immunology
Journal title
Transplantation proceedings → ACNP
ISSN journal
00411345
Volume
30
Issue
5
Year of publication
1998
Pages
2159 - 2160
Database
ISI
SICI code
0041-1345(1998)30:5<2159:ARBVP->2.0.ZU;2-4